DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Plitidepsin is an investigational drug.
There have been 14 clinical trials for Plitidepsin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2010.
The most common disease conditions in clinical trials are Neoplasms, Plasma Cell, Multiple Myeloma, and Lymphoma. The leading clinical trial sponsors are PharmaMar, Apices Soluciones S.L., and Ministry of Health, France.
Recent Clinical Trials for Plitidepsin
|Study to Evaluate the Viral Load Reduction of a Single Dose of Plitidepsin in Adult Patients With COVID-19||Apices Soluciones S.L.||Phase 2|
|Study to Evaluate the Viral Load Reduction of a Single Dose of Plitidepsin in Adult Patients With COVID-19||PharmaMar||Phase 2|
|A Phase 3 Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection||PharmaMar||Phase 3|